Bibliometric Analysis of the Inflammation in Diabetic Cardiomyopathy

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Dec 30

PMID 36582738

Authors

Ning Zhu

Bingwu Huang

Liuyan Zhu

Affiliations

Soon will be listed here.

Abstract

Background: Maladaptive inflammation is implicated in the development of diabetic cardiomyopathy (DCM). This study aimed to visually analyze the global scientific output over the past two decades regarding research on inflammation associated with DCM.

Methods: All relevant articles and reviews were retrieved in the Web of Science (WOS) Core Collection (limited to SCIE) using "inflammation" and "diabetic cardiomyopathy" as search terms. Articles and reviews published from 1 January 2001 to 28 February 2021 were collected. Visualization analysis and statistical analysis were conducted by Microsoft 365 Excel and VOSviewer 1.6.18.

Results: A total of 578 documents were finally selected for further analysis. The publications regarding inflammation and DCM increased gradually over approximately 20 years. The most prolific country was China, with 296 documents and the most citations (9,366). The most influential author groups were Lu Cai and Yihui Tan who were from the United States. The bibliometric analysis of co-occurrence keywords showed that inflammation in DCM is composed of numerous molecules (NF-κB, NLRP3 inflammasome, Nrf-2, TNF-α, protein kinase C, PPARα, TLR4, p38 mitogen-activated protein kinase, TGF-β, Sirt1, and AKT), a variety of cardiac cell types (stem cell, fibroblast, and cardiomyocyte), physiological processes (apoptosis, oxidative stress, autophagy, endoplasmic reticulum stress, hypertrophy, mitochondrion dysfunction, and proliferation), and drugs (sulforaphane, metformin, empagliflozin, and rosuvastatin).

Conclusion: Our bibliometric analysis presents the characteristics and trends of inflammation in DCM and shows that research on inflammation in DCM will continue to be a hotspot.

Citing Articles

Preclinical evidence and possible mechanisms of cardioprotective effects of resveratrol in diabetic cardiomyopathy: a systematic review and meta-analysis.

Yan X, Hu Y, Zhao S, Zhou Q, Chen Q Diabetol Metab Syndr. 2024; 16(1):275.

PMID: 39551777 PMC: 11572515. DOI: 10.1186/s13098-024-01512-8.

The mechanism of TGF-β mediating BRD4/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression.

Bai R, Hao L, Zhou G, Fu Q, Zhang P, Lin P Heliyon. 2024; 10(19):e38188.

PMID: 39391472 PMC: 11466596. DOI: 10.1016/j.heliyon.2024.e38188.

Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis.

Ji Y, An Q, Wen X, Xu Z, Xia Z, Xia Z J Cancer Res Clin Oncol. 2024; 150(6):316.

PMID: 38910204 PMC: 11194221. DOI: 10.1007/s00432-024-05855-7.

Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review.

Shu Y, Li W, Hu Q, Xiong D Medicine (Baltimore). 2023; 102(50):e36478.

PMID: 38115325 PMC: 10727597. DOI: 10.1097/MD.0000000000036478.

References

Wang D, Yin Y, Wang S, Zhao T, Gong F, Zhao Y . FGF1 prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression. Signal Transduct Target Ther. 2021; 6(1):133. PMC: 7991671. DOI: 10.1038/s41392-021-00542-2. View

Pai R, Alathur S . Bibliometric Analysis and Methodological Review of Mobile Health Services and Applications in India. Int J Med Inform. 2020; 145:104330. DOI: 10.1016/j.ijmedinf.2020.104330. View

Wang Y, Zhou S, Sun W, McClung K, Pan Y, Liang G . Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression. Am J Physiol Endocrinol Metab. 2014; 306(11):E1239-47. DOI: 10.1152/ajpendo.00629.2013. View

Sun Y, Zhou S, Guo H, Zhang J, Ma T, Zheng Y . Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metabolism. 2019; 102:154002. DOI: 10.1016/j.metabol.2019.154002. View

Tschope C, Walther T, Escher F, Spillmann F, Du J, Altmann C . Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J. 2005; 19(14):2057-9. DOI: 10.1096/fj.05-4095fje. View

Liu Q, Wang S, Cai L . Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diabetes Investig. 2014; 5(6):623-34. PMC: 4234223. DOI: 10.1111/jdi.12250. View

Luo B, Li B, Wang W, Liu X, Liu X, Xia Y . Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther. 2013; 28(1):33-43. DOI: 10.1007/s10557-013-6498-1. View

Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F . Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J. 2004; 18(7):828-35. DOI: 10.1096/fj.03-0736com. View

Li W, Fang Q, Zhong P, Chen L, Wang L, Zhang Y . EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice. Sci Rep. 2016; 6:24580. PMC: 5263857. DOI: 10.1038/srep24580. View

10.

Synnestvedt M, Chen C, Holmes J . CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2006; :724-8. PMC: 1560567. View

11.

Zheng Z, Ma T, Guo H, Kim K, Kim K, Bi L . 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement. J Cell Mol Med. 2019; 23(8):5771-5781. PMC: 6653553. DOI: 10.1111/jcmm.14493. View

12.

Bugger H, Abel E . Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014; 57(4):660-71. PMC: 3969857. DOI: 10.1007/s00125-014-3171-6. View

13.

Murillo J, Villegas L, Ulloa-Murillo L, Rodriguez A . Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review. Comput Biol Med. 2020; 128:104162. PMC: 7710474. DOI: 10.1016/j.compbiomed.2020.104162. View

14.

Yu L, Dong X, Xue X, Xu S, Zhang X, Xu Y . Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6. J Pineal Res. 2020; 70(1):e12698. DOI: 10.1111/jpi.12698. View

15.

Ji B, Zhao Y, Vymazal J, Mander U, Lust R, Tang C . Mapping the field of constructed wetland-microbial fuel cell: A review and bibliometric analysis. Chemosphere. 2020; 262:128366. DOI: 10.1016/j.chemosphere.2020.128366. View

16.

Li N, Zhou H . SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy. Drug Des Devel Ther. 2020; 14:4775-4788. PMC: 7654518. DOI: 10.2147/DDDT.S269514. View

17.

Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S . Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010; 56(25):2115-25. PMC: 3026637. DOI: 10.1016/j.jacc.2010.07.033. View

18.

Liang D, Zhong P, Hu J, Lin F, Qian Y, Xu Z . EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. J Mol Cell Cardiol. 2015; 82:63-74. DOI: 10.1016/j.yjmcc.2015.02.029. View

19.

Gu X, Xie M, Jia R, Ge S . Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis. Front Med (Lausanne). 2021; 8:675703. PMC: 8175655. DOI: 10.3389/fmed.2021.675703. View

20.

Song S, Ding Y, Dai G, Zhang Y, Xu M, Shen J . Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacol Sin. 2020; 42(2):230-241. PMC: 8027053. DOI: 10.1038/s41401-020-0490-7. View